Product Information

VYTORIN 10-40 MG TABLET is a brand product labeled by Organon LLC, priced at $13.7619 per EA under NDC 78206017602. Its NADAC has been published 202 times since Aug 17, 2022.

The High Outlier badge above means this manufacturer's average price in the ezetimibe and simvastatin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

VYTORIN 10-40 MG TABLET

ezetimibe and simvastatin
$13.7619per EA
High Outlier

Strength

10; 40 mg/1; mg/1

Manufacturer

Organon LLC

NDC

78206017602

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

EZETIMIBE; SIMVASTATIN

Approval Type

New Drug (NDA)

FDA Application

NDA021687

On Market Since

6/1/2021

Pharmacological Classes

Decreased Cholesterol Absorption
Dietary Cholesterol Absorption Inhibitor
HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for VYTORIN 10-40 MG TABLET has been published 202 times since Aug 17, 2022, and over the history we have for it it has risen 20.8%. The table below summarizes its recorded NADAC range and movement.

Current price$13.7619 per EA
All-time high$13.8338 (May 13, 2026)
All-time low$11.3967 (Aug 17, 2022)
52-week high$13.8338
52-week low$13.1460
Median price$12.5677
Average price$12.7031
Largest weekly change+7.0% (Jan 18, 2023)
Weeks tracked202
Tracking sinceAug 17, 2022

Price History

1W

0.0%

1M

+0.3%

3M

-0.5%

6M

+4.5%

1Y

+4.1%

3Y

+12.9%

5Y

N/A

All

+20.8%

Generic Alternatives

The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of VYTORIN 10-40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VYTORIN 10-40 MG TABLET, manufactured by Organon LLC, is $13.7619 per EA (NDC 78206017602), effective Jun 24, 2026.

How has the price of VYTORIN 10-40 MG TABLET changed over time?

Over the history we have for it, the NADAC for VYTORIN 10-40 MG TABLET has risen 20.8%. It has been tracked across 202 weekly CMS publications since Aug 17, 2022.

What are the highest and lowest recorded NADAC prices for VYTORIN 10-40 MG TABLET?

Since Aug 17, 2022, the NADAC for VYTORIN 10-40 MG TABLET has ranged from a low of $11.3967 (Aug 17, 2022) to a high of $13.8338 (May 13, 2026), with a median of $12.5677 per EA.

Are there cheaper alternatives to VYTORIN 10-40 MG TABLET?

Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, EZETIMIBE-SIMVASTATIN 10-40 MG, is $0.3719 per EA — about 97% below VYTORIN 10-40 MG TABLET.

Who manufactures VYTORIN 10-40 MG TABLET?

VYTORIN 10-40 MG TABLET (NDC 78206017602) is labeled by Organon LLC, and CMS classifies it as a brand product.